The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Wild-type p53 can down-modulate the activity of various promoters.
Open accessAbstract
The wild-type (wt) p53 protein is the product of a tumor suppressor gene that is a frequent target for inactivation in many types of tumors. The nuclear localization of the protein, as well as additional features, suggest that it may be involved in the regulation of gene expression. To explore this possibility, the effects of overproduced wt p53 were investigated in a number of systems. Induction of growth arrest via the antiproliferative effect of wt p53 greatly impaired the ability of cells to exhibit an increase in c-fos mRNA upon serum stimulation. Experiments in which cells were cotransfected with p53 expression plasmids together with a reporter gene linked to various promoters revealed that wt p53 could effectively reduce transcription from a series of promoters derived from serum-inducible genes, but not from a major histocompatibility complex gene. The p53-mediated repression of c-fos gene expression occurred even in the presence of cycloheximide. Kinetic studies indicate that the effect of wt p53 is rapid, rather than representing a secondary consequence of growth arrest. These findings support a role for p53 in transcriptional regulation, perhaps by reducing the expression of genes that are needed for ongoing cell proliferation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene
Greenberg, M. E., & Ziff, E. B. (1984) · Nature · doi:10.1038/311433a0 · Cited by 3,064
The p53 proto-oncogene can act as a suppressor of transformation
Finlay, C. A., Hinds, P. W., & Levine, A. J. (1989) · Cell · doi:10.1016/0092-8674(89)90045-7 · Cited by 1,987
Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K. V., & Vogelstein, B. (1990) · Science · doi:10.1126/science.2144057 · Cited by 1,754
Induction of c-fos gene and protein by growth factors precedes activation of c-myc
Müller, R., Bravo, R., Burckhardt, J., & Curran, T. (1984) · Nature · doi:10.1038/312716a0 · Cited by 1,369
Treisman, R. (1986) · Cell · doi:10.1016/0092-8674(86)90882-2 · Cited by 847
Presence of a Potent Transcription Activating Sequence in the p53 Protein
Fields, S., & Jang, S. K. (1990) · Science · doi:10.1126/science.2144363 · Cited by 790
Gritz, L., & Davies, J. (1983) · Gene · doi:10.1016/0378-1119(83)90223-8 · Cited by 788
p53 functions as a cell cycle control protein in osteosarcomas.
Diller, L., Kassel, J., Nelson, C. E., Gryka, M. A., Litwak, G., Gebhardt, M., Bressac, B., Ozturk, M., Baker, S. J., & Vogelstein, B. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.11.5772 · Cited by 772
Michalovitz, D., Halevy, O., & Oren, M. (1990) · Cell · doi:10.1016/0092-8674(90)90113-s · Cited by 769
Self-citationA gene activated by growth factors is related to the oncogene v-jun.
Ryder, K., Lau, L. F., & Nathans, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.5.1487 · Cited by 735
Wild-type p53 can inhibit oncogene-mediated focus formation.
Eliyahu, D., Michalovitz, D., Eliyahu, S., Pinhasi-Kimhi, O., & Oren, M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.8763 · Cited by 692
Self-citationTranscriptional Activation by Wild-Type but Not Transforming Mutants of the p53 Anti-Oncogene
Raycroft, L., Wu, H., & Lozano, G. (1990) · Science · doi:10.1126/science.2144364 · Cited by 619
Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines.
Bártek, J., Iggo, R. D., Gannon, J., & Lane, D. P. (1990) · PubMed · Cited by 603
Transcriptional autoregulation of the proto-oncogene fos
Sassone-Corsi, P., Sisson, J. C., & Verma, I. M. (1988) · Nature · doi:10.1038/334314a0 · Cited by 595
Hinds, P., Finlay, C., & Levine, A. J. (1989) · Journal of Virology · doi:10.1128/jvi.63.2.739-746.1989 · Cited by 577
Transcriptional activation of c-jun during the G0/G1 transition in mouse fibroblasts
Ryseck, R.-P., Hirai, S. I., Yaniv, M., & Bravo, R. (1988) · Nature · doi:10.1038/334535a0 · Cited by 556
Self-citationCellular localization and cell cycle regulation by a temperature-sensitive p53 protein.
Martinez, J., Georgoff, I., Martinez, J., & Levine, A. J. (1991) · Genes & Development · doi:10.1101/gad.5.2.151 · Cited by 527
Genetic Mechanisms of Tumor Suppression by the Human p53 Gene
Chen, P.-L., Chen, Y., Bookstein, R., & Lee, W.-H. (1990) · Science · doi:10.1126/science.2274789 · Cited by 518
Growth regulation of a cellular tumour antigen, p53, in nontransformed cells
Reich, N. C., & Levine, A. J. (1984) · Nature · doi:10.1038/308199a0 · Cited by 494
Mercer, W. E., Shields, M. T., Amin, M., Sauve, G. J., Appella, E., Romano, J. W., & Ullrich, S. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.16.6166 · Cited by 477
Characterization of junD: a new member of the jun proto-oncogene family.
Hirai, S. I., Ryseck, R. P., Mechta, F., Bravo, R., & Yaniv, M. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03525.x · Cited by 474
Self-citationInducible production of c-fos antisense RNA inhibits 3T3 cell proliferation.
Holt, J. T., Gopal, T. V., Moulton, A. D., & Nienhuis, A. W. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4794 · Cited by 439
Santhanam, U., Ray, A., & Sehgal, P. B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7605 · Cited by 375
Antisense RNA of proto-oncogene c-fos blocks renewed growth of quiescent 3T3 cells.
Nishikura, K., & Murray, J. M. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.2.639 · Cited by 372
Negative regulation of human c-fos expression by thes retinoblastoma gene product
Robbins, P. D., Horowitz, J. M., & Mulligan, R. C. (1990) · Nature · doi:10.1038/346668a0 · Cited by 287
Epidermal growth factor stimulates transcription of the c-jun proto-oncogene in rat fibroblasts
Quantin, B., & Breathnach, R. (1988) · Nature · doi:10.1038/334538a0 · Cited by 274
Mercer, W. E., Shields, M. T., Lin, D., Appella, E., & Ullrich, S. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1958 · Cited by 249
Different Tumor-Derived p53 Mutants Exhibit Distinct Biological Activities
Halevy, O., Michalovitz, D., & Oren, M. (1990) · Science · doi:10.1126/science.2218501 · Cited by 234
Self-citationMultiple sequence elements in the c-fos promoter mediate induction by cAMP.
Fisch, T. M., Prywes, R., Simon, M. C., & Roeder, R. G. (1989) · Genes & Development · doi:10.1101/gad.3.2.198 · Cited by 221
Wang, E. H., Friedman, P. N., & Prives, C. (1989) · Cell · doi:10.1016/0092-8674(89)90913-6 · Cited by 207
The p53 protein and its interactions with the oncogene products of the small DNA tumor viruses
Levine, A. J. (1990) · Virology · doi:10.1016/0042-6822(90)90505-l · Cited by 192
Hunter, T. (1985) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(85)90087-8 · Cited by 177
Cannon, J. V., & Lane, D. P. (1991) · Nature · doi:10.1038/349802a0 · Cited by 173
Levine, A. J. (1990) · BioEssays · doi:10.1002/bies.950120203 · Cited by 168
Mutant p53 proteins bind DNA abnormally in vitro.
Kern, S. E., Kinzler, K. W., Baker, S. J., Nigro, J. M., Rotter, V., Levine, A. J., Friedman, P. N., Prives, C. L., & Vogelstein, B. (1991) · PubMed · Cited by 163
The MCK enhancer contains a p53 responsive element.
Weintraub, H., Hauschka, S., & Tapscott, S. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4570 · Cited by 159
Ginsberg, D., Michael, D., Ginsberg, D., & Oren, M. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.1.582 · Cited by 142
Self-citationras -Induced Neuronal Differentiation of PC12 Cells: Possible Involvement of fos and jun
Sassone‐Corsi, P., Der, C. J., & Verma, I. M. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.8.3174 · Cited by 132
A potential transcriptional activation element in the p53 protein.
O’Rourke, R. W., Cw, M., Kato, G. J., Simon, K. J., Dl, C., Dang, C. V., & Hp, K. (1990) · PubMed · Cited by 128
The E1A 13S Product of Adenovirus 5 Activates Transcription of the Cellular Human HSP70 Gene
Wu, B. J., Hurst, H. C., Jones, N., & Morimoto, R. I. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.8.2994 · Cited by 123
Melloul, D., Aloni, B., Calvo, J. M., Yaffe, D., & Nudel, U. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb01917.x · Cited by 111
DNA binding properties of murine p53.
Steinmeyer, K., & Deppert, W. (1988) · PubMed · Cited by 96
Rotter, V., Abutbul, H., & Ben‐Ze'ev, A. (1983) · The EMBO Journal · doi:10.1002/j.1460-2075.1983.tb01543.x · Cited by 94
Expression of the p53 protein during the cell cycle of human peripheral blood lymphocytes
Mercer, W. E., & Baserga, R. (1985) · Experimental Cell Research · doi:10.1016/0014-4827(85)90233-2 · Cited by 92
Jenkins, J. R., Chumakov, P. M., Addison, C. M., Stürzbecher, H. W., & Wade-Evans, A. M. (1988) · Journal of Virology · doi:10.1128/jvi.62.10.3903-3906.1988 · Cited by 89
Protein-binding elements in the promoter region of the mouse p53 gene.
Ginsberg, D., Oren, M., Yaniv, M., & Piette, J. (1990) · PubMed · Cited by 73
Self-citationEhrlich, R. L., Maguire, J. E., & Singer, D. S. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.2.695 · Cited by 66
Transactivation of the p53 oncogene by E1a gene products
Braithwaite, A. W., Nelson, C. C., Skulimowski, A., McGovern, J., Pigott, D., & Jenkins, J. R. (1990) · Virology · doi:10.1016/0042-6822(90)90525-v · Cited by 48
Cited by
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The first 30 years of p53: growing ever more complex.
Levine, A. J., & Oren, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2723 · Cited by 1,967
Self-citationmdm2 expression is induced by wild type p53 activity.
Barak, Y., Juven, T., Haffner, R., & Oren, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05678.x · Cited by 1,290
Self-citationDecision making by p53: life, death and cancer
Oren, M. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401183 · Cited by 1,068
Self-citationOncogenic forms of p53 inhibit p53-regulated gene expression
Kern, S., Pietenpol, J., Thiagalingam, S., Seymour, A., Kinzler, K., & Vogelstein, B. (1992) · Science · doi:10.1126/science.1589764 · Cited by 940
Metadata
- Authors
- Ginsberg, D., Mechta, F., Yaniv, M., & Oren, M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1991-11-15
- Volume
- 88
- Issue
- 22
- Pages
- 9979-9983
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2029529223
- Cited by
- 435
- References
- 48
- FWCI
- 17.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.